Mgta-456, a Cell Therapy Utilizing Expansion of CD34+ Hematopoietic Stem Cells (HSC), Improves HLA Matching for Adult Recipients, Promotes Faster Hematopoietic Recovery and Enables Uniform Engraftment with Less Acute Graft-Vs-Host Disease (GVHD)
Wagner, John E., Brunstein, Claudio G., McKenna, David H., Sumstad, Darin, Miller, Jeffrey S., Blazar, Bruce R., Defor, Todd E., Boitano, Anthony E., Cooke, Michael P., Raffel, Glen D., Davis, John C.Volume:
26
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2019.12.222
Date:
March, 2020
File:
PDF, 190 KB
2020